The PI3Kδ Inhibitor Zandelisib on Intermittent Dosing in Relapsed/refractory Follicular Lymphoma: Results from a Global Phase 2 Study
Andrew D. Zelenetz,Wojciech Jurczak,Vincent Ribrag,Kim Linton,Graham P. Collins, Javier L. Jimenez,Mark Bishton,Bhagirathbhai Dholaria,Andrea Mengarelli,Tycel J. Phillips, Nagendraprasad Sungala,Gerardo Musuraca,Oonagh Sheehy, Eric Van Den Neste,Mitsuhiko Odera, Lu Miao,Daniel P. Gold,Richard G. Ghalie,Pier L. Zinzani HEMASPHERE（2024）
AI 理解论文
溯源树
样例
